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Cysteine oxidation of the two RNA recognition motifs (RRM1 and RRM2) of TDP-43, a multi-domain
protein involved in neurodegenerative diseases, results in loss of function and accumulation of
insoluble aggregates under both in vitro and in vivo conditions. However, the molecular mecha-
nisms linking cysteine oxidation to protein aggregation and functional aberration remain
unknown. We report that oxidation of cysteines in RRM1, but not in other domains, induced confor-
mational changes which subsequently resulted in protein aggregation and loss of nucleic acid-bind-
ing activity. Thus, oxidation-induced conformational change of RRM1 plays a key role in TDP-43
aggregation and disease progression.
Structured summary of protein interactions:
RRM2 and RRM2 bind by molecular sieving (View Interaction: 1, 2, 3, 4)
RRM1 and RRM1 bind by comigration in sds page (View Interaction: 1, 2, 3)
RRM1 and RRM1 bind by classical ﬂuorescence spectroscopy (View interaction)
RRM2 and RRM2 bind by molecular sieving (View Interaction: 1, 2)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Trans-activating response region DNA-binding protein with a
molecular mass of 43 kDa (TDP-43) is a ubiquitously expressed
DNA/RNA-binding protein highly conserved among mammals
and invertebrates [1]. Although originally identiﬁed as a transcrip-
tional repressor of type 1 human immunodeﬁciency virus (HIV-1)
DNA [2], it was later shown to play a role in RNA processing and
transcriptional regulation [3–5]. Large-scale RNA-sequencing stud-
ies revealed TDP-43-binding sites on a large number of mRNAs,
with many of them involved in synaptic function and neuronaldevelopment [6,7]. TDP-43 has been found to be a major compo-
nent of pathological inclusions obtained from patients afﬂicted
with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar
degeneration (FTLD) [8]. TDP-43 inclusions have also been identi-
ﬁed as secondary pathological features in a wide spectrum of neu-
rodegenerative diseases, including Alzheimer’s disease (AD),
Parkinson’s disease (PD) and Huntington’s disease (HD) [9].
Structural studies revealed that TDP-43 is arranged into four
domains (Fig. 1A): an N-terminal domain (NTD) that is partially
structured and is probably involved in protein oligomerization
[10], followed by two RNA-recognition motifs (RRM1 and RRM2)
capable of binding nucleic acids [11,12], and ending in an intrinsi-
cally disordered C-terminal domain (CTD) implicated in protein
interactions [13–15]. The NTD, RRM1 and RRM2 contain two cyste-
ines each, marking them as prime targets for oxidative attack. Oxi-
dation of cysteines located at RRM1 and RRM2 decreased protein
solubility by promoting the formation of inter- and intra-molecular
disulﬁde linkage [16], providing a strong link between inclusion
formation and direct protein oxidation. Oxidized TDP-43 also lost
the ability to inhibit splicing, suggesting that oxidation of TDP-43
is a loss-of-function event. However, the molecular mechanisms
linking cysteine oxidation to protein aggregation and functional
aberration is not known.
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Fig. 1. Oxidative attack on RRM1 induces aggregation. (A) Schematic of protein constructs used in this study. Positions of cysteine residues are also marked. Average turbidity
of (B) 42 lMNTD, (C) 40 lM RRM1, (D) 330 lM RRM2 and (E) 44 lM RRM1 + 2 shows that only constructs that contain RRM1 are susceptible to irreversible aggregation after
oxidation. Each experiment was carried out in duplicate.
576 C.-k. Chang et al. / FEBS Letters 587 (2013) 575–582Here, we report that oxidation of RRM1, but not other domains,
resulted in irreversible protein aggregation, even though all three
domains formed oligomers with disulﬁde crosslinks in solution.
We demonstrate that oxidation of RRM1 proceeds in a sequential
manner and causes conformational changes and impaired nucleic
acid binding activity. These results suggest a direct structural and
functional link between TDP-43 oxidation and pathological aggre-
gation, and highlight RRM1 as a prime target for oxidative attack in
TDP-43.2. Materials and methods
2.1. Protein expression and puriﬁcation
pQE-30 (Qiagen, CA) vectors encoding the RRM1 domain (res.
101–191) or RRM2 domain (res. 192–265) of TDP-43 with a N-ter-
minal His6-tag was a kind gift from Dr. Hanna Yuan (Institute of
Molecular Biology, Academia Sinica). Modiﬁed pET-17b encoding
the N-terminal domain of TDP-43 with a N-terminal His6-tag was
C.-k. Chang et al. / FEBS Letters 587 (2013) 575–582 577a kind gift from Dr. Joseph Jen-Tse Huang (Institute of Chemistry,
Academia Sinica). Protein expression and puriﬁcation followed
previously described procedures [10,12]. Proteins were completely
reduced with 50 mM DTT and exchanged into PBS with an Amicon
concentrator (Millipore, MA) prior to conducting experiments.
2.2. Turbidity measurements
Protein in PBS was treated with 10 mMH2O2 or PBS (control) for
10 min. A third set of samples were oxidized with 10 mM H2O2 for
10 min then immediately reduced with 50 mM DTT. Turbidity of
the samples was measured in the form of absorbance at 405 nm
through an Ultrospec 6300 Pro spectrophotometer (GE Healthcare,
MA) at room temperature over time.Soluble Insoluble Control
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Fig. 2. Oxidized RRM1 contains multiple oligomer species and impairs binding to nucleic
in the soluble and insoluble fraction after oxidation. (C) Free sulfhydryl content of sol
Denaturing gel electrophoresis of the soluble (Sup.) and insoluble (Pellet) fraction of oxi
Electrophoretic mobility shift assay of ss(TG)6 mixed with oxidized RRM1. C: DNA-only; 1
DTT. (A), (B) and (C) were carried out in duplicate with the average shown in the ﬁgure2.3. Determination of free sulfhydryl content and protein amount in
soluble and insoluble fractions
After oxidation, aggregates were spun down at 14000g for
30 min and the supernatant transferred to a clean tube. Free sulf-
hydryl content of the pellet and supernatant was determined with
5-(3-carboxy-4-nitrophenyl)disulfanyl-2-nitrobenzoic acid (DTNB)
assay following manufacturer’s suggestion (Invitrogen, CA).
2.4. Denaturing gel electrophoresis
Protein samples were mixed with SDS loading buffer in the
presence and absence of b-mercaptoethanol (bME) following stan-
dard protocols.D Sup.
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578 C.-k. Chang et al. / FEBS Letters 587 (2013) 575–5822.5. Surface hydrophobicity assay with SYPRO Orange
RRM1 was mixed with 10 SYPRO Orange (Invitrogen, CA) in
the presence and absence of 10 mM H2O2 on a 96-well microplate
to a ﬁnal concentration of 40 lM. Fluorescence was monitored on a
Gemini EM ﬂuorescence microplate reader (Molecular Devices, CA)
using excitation and emission wavelengths of 472 and 570 nm,
respectively. Readings were taken every minute for a total of
60 min.
2.6. Electrophoretic mobility shift assay (EMSA)
100 nM single-stranded (TG)6 DNA with 6-carboxyﬂuorescein
(FAM) at its 50-end (Protech Systems, Taiwan) was mixed with
0.5 mg/ml of control, oxidized, or reduced RRM1 in PBS for
30 min at room temperature. Electrophoresis and data acquisition
followed previously described procedures [17].
2.7. Nuclear magnetic resonance (NMR) spectroscopy
All spectra were acquired on 600-MHz Bruker Avance spec-
trometers equipped with cryo-probes at 25 C. RRM1 backbone
assignment followed previously described procedures [18]. The full
assignment has been deposited to the BMRB with accession num-
ber 18765. Oxidation reactions were initiated by the addition of
10 mM H2O2 to 43 lM protein. 15N-HSQC spectra were acquired
after 10 min with an acquisition time of 61 min for each spectrum.A B
C
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HSQC spectrum acquired. Spectra were processed and analyzed
on iNMR (Nucleomatica, Italy) and CCPN Analysis [19].
2.8. Analytical size exclusion chromatography (SEC)
Oxidized protein was loaded on an AKTA fast protein liquid
chromatography system equipped with a HiLoad Superdex-75/60
column (GE Healthcare, MA) pre-calibrated with the Gel Filtration
LMW Calibration Kit (GE Healthcare, MA). PBS was used as the run-
ning buffer with a ﬂow rate of 1 ml/min at 4 C. The elution proﬁle
was monitored through the optical absorbance at 280 nm.
2.9. Molecular visualization
Structural coordinates of RRM1 and RRM2 were obtained from
the Protein Data Bank entries No. 2CQG and 1WF0, respectively.
All structure ﬁgures were prepared in PyMol 1.4 [20].
3. Results
3.1. Oxidation of RRM1, but not NTD or RRM2, induces irreversible
protein aggregation
A comprehensive study of the oxidation effect on each cysteine-
containing domain was carried out (Fig. 1A). We determined
whether H2O2 treatment of the NTD, RRM1 or RRM2 would resultSupernatant Control
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Fig. 4. RRM1 oxidation induces exposure of hydrophobic residues. (A) Binding of
SYPRO Orange to RRM1 is enhanced in the presence of H2O2. Each curve represents
the average of three repeats. (B) Denaturing gel electrophoresis in the absence of
reducing agents of RRM1 after oxidation. Cysteine oxidation coincides with the
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RRM1 showed increased turbidity after treatment (Fig. 1C). Addi-
tion of a reducing agent such as DTT to RRM1 10 min after the start
of oxidation treatment prevented protein aggregation. However,
once turbidity reached a plateau, DTT treatment was unable to re-
verse the aggregation (results not shown). Lower amount (1 mM)
of H2O2 also induced RRM1 aggregation at a slower rate (Supple-
mental Figure S1), indicating that the aggregation process is not
due to an extraneous amount of oxidant. RRM1 + 2, comprised of
tandem RRM1 and RRM2, also showed increased turbidity after
oxidation, with a shorter lag time compared to RRM1 alone
(Fig. 1E). This suggested that inclusion of RRM2 enhanced the
aggregation of RRM1 under oxidizing conditions. Even the control
and DTT-reduced RRM1 + 2 samples started to show turbidity
changes after 150 min, presumably due to oxidation in air. This
observation further indicates that RRM1 + 2 is more susceptible
to oxidation than RRM1 alone.
3.2. Oxidation of RRM1 forms multiple disulﬁde-linked oligomer
species and impairs binding to DNA
We next characterized the aggregation properties of RRM1
(Fig. 2). We found that increasing RRM1 concentration shortened
the lag time before turbidity started to appear while the ﬁnal tur-
bidity and the relative amount of insoluble protein both increased
(Fig. 2A and B). Regardless of the initial protein concentration, the
cysteines of insoluble RRM1 were almost fully oxidized, whereas
the protein in the soluble fraction contained decreasing amounts
of reduced cysteines with increasing RRM1 concentration
(Fig. 2C). The free sulfhydryl content of the soluble fraction at
0.5 mg/ml protein concentration was 70%, indicating that most
of the protein had a single cysteine oxidized. At 1.5 mg/ml protein
concentration, the free sulfhydryl content of the soluble fraction
was below 50%, which indicated that some RRM1 had both cyste-
ines oxidized yet remained soluble. Thus, oxidation of both cyste-
ines in RRM1 is necessary, but not sufﬁcient, to produce insoluble
aggregates.
Cohen et al. observed that oxidation of both recombinant and
cellular TDP-43 led to the generation of disulﬁde-linked oligomers
[16]. We tested whether oxidized RRM1 also formed disulﬁde-
linked oligomers by denaturing gel electrophoresis in the presence
and absence of bME (Fig. 2D). The soluble fraction contained a
majority of monomer RRM1 with 10% of disulﬁde-linked dimers
and trimers. On the other hand, the insoluble fraction was almost
exclusively composed of disulﬁde-linked oligomers, with dimer
being the predominant species, suggesting that inter-molecular
disulﬁde bridge formation of RRM1 is necessary for aggregate
formation.
Oxidation of TDP-43 has also been reported to impair its splic-
ing function [16], and since RRM1 is the major nucleic acid-binding
domain of TDP-43 [11,12], we examined the ability of oxidized
RRM1 to bind to a single-stranded TG-hexarepeat (ss(TG)6) DNA
by EMSA (Fig. 2E). Untreated protein (lane 1) was able to bind to
ss(TG)6 as evidenced by the smearing pattern compared to the con-
trol (lane C), whereas protein treated with 10 mM H2O2 (lane 2)
lost most of its binding activity. If the protein was treated with
DTT immediately after H2O2-treatment (lane 3), it retained almost
all of its binding activity. These results indicate that oxidation of
RRM1 cysteines impaired its nucleic acid-binding activity.
3.3. Oxidized NTD and RRM2 form soluble disulﬁde-linked oligomers
We measured the free sulfhydryl content of both NTD and
RRM2 under the same oxidative conditions as RRM1 (Fig. 3A and
B). NTD and RRM2 were completely oxidized after H2O2 treatment.
Analytical size exclusion chromatography (Fig. 3C and D) anddenaturing gel electrophoresis (Fig. 3E and F) were then used to
characterize the oxidized species. For NTD, peak C of the chromato-
gram (Fig. 3C) corresponded to trimers (30 kDa), but contained
only a small fraction of disulﬁde-linked species (Fig. 3E). Peaks A
and B (Fig. 3C) corresponded to larger oligomers consisted mostly
of various disulﬁde-linked species (Fig. 3E, lane C). Unlike oxidized
RRM1 (Fig. 2D), a considerable amount of NTD protein from peaks
A and B was also resistant to bME reduction in the gel. We recently
found that the NTD is able to oligomerize by itself, which may oc-
clude the cysteines and lead to incomplete reduction by bME [10].
Multiple disulﬁde-linked oligomer species were also observed
for oxidized RRM2. Peak D of the chromatogram (Fig. 3D) corre-
sponded to the monomer species (9 kDa). Peak C corresponded
to dimers and started to show presence of disulﬁde-linked species
when electrophoresed on a denaturing gel (Fig. 3F). Peaks A and B
corresponded to high-order oligomers, and contained multiple
disulﬁde-linked oligomer species. A small portion of the high-order
oligomers was resistant to bME treatment, although not to the ex-
tent of that observed for NTD. Our results suggest that oxidized
NTD and RRM2 oligomers remained soluble in solution and under-
score the unique aggregation behavior of RRM1.
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To test whether oxidation of the cysteine residue caused confor-
mational change of RRM1, we took advantage of the unique ﬂuores-
cence properties of SYPROOrangedye. SYPROOrange is quenched in
an aqueous environment, but is able to bind to exposedhydrophobic
patchesonaprotein andbecomeunquenched [21]. It is thuspossible
to monitor the increase in ﬂuorescence as a measure of exposed
hydrophobicity. We did observe increased ﬂuorescence after treat-
ing RRM1 with H2O2 compared to untreated protein (Fig. 4A). The
dip inﬂuorescenceat theendof theexperimentwasprobablycaused
by the start of protein aggregation, which would decrease the num-
ber of dye-association sites [21].Wealsoobserved increasing forma-
tion of disulﬁde-linked species in a time-dependent manner after
H2O2 treatment (Fig. 4B),which suggests that exposedhydrophobic-
ity correlated with thiol oxidation in RRM1.
3.5. H2O2 preferentially oxidizes Cys
173 of RRM1
An overlay of the 15N-HSQC spectra of uniformly-labeled 15N-
RRM1 in the reduced (blue) and H2O2-oxidized (red) states isshown on Fig. 5A. Oxidation caused signiﬁcant changes in the
15N-HSQC spectrum in a time dependent manner (Supplemental
Figure S2). The most prominent change was the gradual disappear-
ance of several resonances (strong perturbations, labeled red in
Fig. 5A). Concurrently, there are several resonances showing slight
but discernible (60.05 ppm) chemical shift changes (weak pertur-
bations, labeled black). The intensity change with time of some
typical strongly perturbed resonances is shown on Fig. 5B. The
intensities were normalized against the initial intensity of each
resonance prior to the addition of peroxide as 100%. Some reso-
nances not affected by oxidation are also shown as controls, which
lose intensity due to formation of soluble and insoluble aggregates.
The strongly perturbed residues lost their intensities at much fas-
ter rate than controls, suggesting changes in the local conforma-
tion. Between the two cysteines, Cys173 showed much stronger
perturbation than Cys175, and since the soluble protein was pri-
marily oxidized at a single cysteine (Fig. 2C), these results strongly
suggested that Cys173 is preferentially oxidized over Cys175.
The perturbations on NMR spectra of the soluble RRM1 protein
caused by H2O2 oxidation can be mapped onto the structure of the
reduced RRM1 (Fig. 6A,B). The most perturbed residues are
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and weak (orange/yellow) perturbations from Fig. 5 are mapped on (A) cartoon and
(B) surface representations of RRM1 structure. (C) and (D) illustrate the positions
and accessibility of cysteine side chains in RRM1 and RRM2, respectively.
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terminus of the b1-strand. The weakly perturbed residues are
mostly located in either the b strands or the a1-helix. Taken to-
gether, the structural perturbations are not limited to the vicinity
of the two cysteine residues but spreads over the entire b-sheet
and even the a1 helix, which interacts with the b-sheet.
4. Discussion
We demonstrated that although NTD, RRM1 and RRM2 can all
be oxidized and formed cross-linked oligomers, only RRM1 oxida-
tion leads to TDP-43 aggregation. Our results suggest that oxida-
tion of RRM1 proceeds in a sequential manner. Cys173 was
preferentially oxidized, resulting in conformational change of
RRM1. This led to further oxidation of Cys175 and crosslinking of
RRM1 monomer to form insoluble RRM1 dimer aggregate with im-
paired nucleic acid binding afﬁnity. The molecular event of perox-
ide oxidation can be depicted according to the following scheme:
RRM1C173R;C175R ! RRM1C173O;C175R ! RRM1C173O;C175O
! ðRRM1C173O;C175OÞ2 #;
where ‘‘R’’ and ‘‘O’’ denote the reduced and oxidized forms of cyste-
ines, respectively.
Why is oxidation of RRM1 more crucial in inducing protein
aggregation than oxidation of NTD or RRM2? Cys173 and Cys175 in
RRM1 are located in b4 strand sandwiched in between of two
loops, that between b2–b3 and b4–a2, and the thiol groups are
buried inside the interior (Fig. 6C) and are inaccessible for oxida-
tion or cross-linking as reﬂected by their slow oxidation (compare
Fig. 2C with Fig. 3A and 3B), whereas Cys198 and Cys244 in RRM2 are
located in loop regions that are often more ﬂexible and solvent
accessible [22,23] (Fig. 6D). The ﬂexibility of the two cysteine res-
idues in RRM2 is likely the reason of the missing electron density of
the backbone atoms of these two residues in the X-ray crystal
structure of RRM2 [12]. We have previously shown that the NTDcontains mostly disordered sequence with a structured region
and it promote oligomerization and enhance DNA binding [10].
At present the structure of the NTD is not available, however, judg-
ing from the lack of aggregation after oxidation (Fig. 1B), Cys39 and
Cys50 are more likely to be relatively accessible and not buried in-
side a protein core.
Oxidation of a buried cysteine would change local electrostatics
and destabilize hydrophobic interactions surrounding the oxida-
tion site, leading to local unfolding and exposure of hydrophobic
residues. The structural consequences would not happen for ex-
posed cysteine residues or residues in the ﬂexible region, such as
those of RRM2 and NTD, and hence no aggregation was observed.
In contrast, the conformation of RRM1 was altered when only the
Cys173 was oxidized and severe aggregation occurred when
Cys175 was subsequently oxidized. In further support of the critical
structural role of cysteines we found that RRM1C173S or RRM1C175S
mutants where either the Cys173 or Cys175 residue was mutated to
serine were prone to degradation when expressed in Escherichia
coli cells compared to wild-type RRM1 (Supplemental Figure S3).
The observation that oxidation-induced conformational change in
RRM1 is irreversible under our conditions raises an important issue
regarding the role of RRM1 cysteines as a reversible switch in re-
dox signaling [24].
Although oxidation of NTD or RRM2 did not directly lead to
aggregation, they may act as facilitators by further enhancing the
speed and severity of RRM1 aggregation (Fig. 2A and B). This pos-
sibility is consistent with our turbidity results, where the presence
of RRM2 in RRM1 + 2 enhanced aggregation compared to RRM1
alone (compare Fig. 1C and E). Mutations that introduce additional
cysteine residues at solvent accessible sites, such as the ALS-asso-
ciated G348C and S379C mutants, may enhance aggregation by
acting as extra oligomerization sites in a manner similar to NTD/
RRM2 [25,26]. The central role of RRM1 in oxidation-induced
TDP-43 aggregation suggests that it could serve as a primary target
for development of antioxidant-based therapies against TDP-43
proteinopathies.
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